Holden Stuart bought URGN
August 26, 2025 · Form 4 insider transaction
Holden Stuart bought 8,000 shares of UroGen Pharma Ltd. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Acquired (buy-side)
Shares
8,000
Price
$0.00
Total value
N/A
InsiderHolden Stuart
Role—
CompanyUroGen Pharma Ltd. (URGN)
SecurityRestricted Stock Unit
Transaction codeA: Grant or award
Transaction dateAugust 26, 2025
Filing dateAugust 27, 2025
Shares owned after8,000
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each restricted stock unit ("RSU") represents a contingent right to receive one ordinary share of the Issuer; The shares underlying the RSUs will vest in equal quarterly installments over a period of one year, subject to the director's Continuous Service (as defined in the 2017 Equity Incentive Plan) through such vesting dates.